Madrigal Pharmaceuticals Inc (MDGL):企業の財務・戦略的SWOT分析

◆英語タイトル:Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1684
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Madrigal Pharmaceuticals Inc (MDGL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Madrigal Pharmaceuticals Inc (Madrigal) formerly, Synta Pharmaceuticals Corp is a biopharmaceutical company focused on the development and commercialization of novel therapeutic candidates for the treatment of liver, cardiovascular and metabolic diseases. Its lead product candidate, MGL-3196, is a proprietary, liver-directed, selective thyroid hormone receptor beta, (THR-beta), agonist that can potentially be used for treating several disease with high unmet medical need. The company is developing MGL-3196 for non-alcoholic steatohepatitis (NASH) non-alcoholic fatty liver disease (NAFLD), associated dyslipidemias and familial hypercholesterolemia (FH). The company is also developing MGL-3745 (THR-beta agonist), a preclinical compound that has similar thyroid receptor selectivity to MGL-3196. Madrigal is headquartered in West Conshohocken, Pennsylvania, the US.

Madrigal Pharmaceuticals Inc Key Recent Developments

Feb 26,2020 Madrigal Pharmaceuticals reports 2019 fourth quarter and full year financial results and highlights
Nov 06,2019 Madrigal Pharmaceuticals reports 2019 third quarter financial results and highlights
Jul 02,2019 Madrigal Pharmaceuticals announces appointment of Jim Daly to board of directors
May 08,2019 Madrigal Pharmaceuticals reports 2019 first quarter financial results and highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Madrigal Pharmaceuticals Inc – Key Facts
Madrigal Pharmaceuticals Inc – Key Employees
Madrigal Pharmaceuticals Inc – Key Employee Biographies
Madrigal Pharmaceuticals Inc – Major Products and Services
Madrigal Pharmaceuticals Inc – History
Madrigal Pharmaceuticals Inc – Company Statement
Madrigal Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Madrigal Pharmaceuticals Inc – Business Description
R&D Overview
Madrigal Pharmaceuticals Inc – Corporate Strategy
Madrigal Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Madrigal Pharmaceuticals Inc – Strengths
Madrigal Pharmaceuticals Inc – Weaknesses
Madrigal Pharmaceuticals Inc – Opportunities
Madrigal Pharmaceuticals Inc – Threats
Madrigal Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Madrigal Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 26, 2020: Madrigal Pharmaceuticals reports 2019 fourth quarter and full year financial results and highlights
Nov 06, 2019: Madrigal Pharmaceuticals reports 2019 third quarter financial results and highlights
Jul 02, 2019: Madrigal Pharmaceuticals announces appointment of Jim Daly to board of directors
May 08, 2019: Madrigal Pharmaceuticals reports 2019 first quarter financial results and highlights
Feb 27, 2019: Madrigal Pharmaceuticals Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Madrigal Pharmaceuticals Inc, Key Facts
Madrigal Pharmaceuticals Inc, Key Employees
Madrigal Pharmaceuticals Inc, Key Employee Biographies
Madrigal Pharmaceuticals Inc, Major Products and Services
Madrigal Pharmaceuticals Inc, History
Madrigal Pharmaceuticals Inc, Subsidiaries
Madrigal Pharmaceuticals Inc, Key Competitors
Madrigal Pharmaceuticals Inc, Ratios based on current share price
Madrigal Pharmaceuticals Inc, Annual Ratios
Madrigal Pharmaceuticals Inc, Annual Ratios (Cont...1)
Madrigal Pharmaceuticals Inc, Interim Ratios
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Madrigal Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Madrigal Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Madrigal Pharmaceuticals Inc, Ratio Charts
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Madrigal Pharmaceuticals Inc (MDGL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OncoResponse Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OncoResponse Inc (OncoResponse) focuses on the discovery, development and commercialization of therapeutic antibodies for the treatment of cancer. The company’s lead program includes ONCR-201, an anti-EMP2 fully-human monoclonal antibody, which is developed for female malignancies. It utiliz …
  • Noble Energy, Inc.:戦略・SWOT・企業財務分析
    Noble Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Noble Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Saniona AB (SANION):製薬・医療:M&Aディール及び事業提携情報
    Summary Saniona AB (Saniona), formerly Aniona is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …
  • Ulthera Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ulthera Inc (Ulthera), a subsidiary of Merz Pharma GmbH & Co KgaA is a medical device company that develops and commercializes technologies for aesthetic and medical applications by using its therapeutic ultrasound platform technologies. The company’s therapeutic ultrasound platform technolo …
  • PTT Global Chemical Public Co Ltd (PTTGC):企業の財務・戦略的SWOT分析
    PTT Global Chemical Public Co Ltd (PTTGC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Fukuda Denshi Co Ltd (6960):医療機器:M&Aディール及び事業提携情報
    Summary Fukuda Denshi Co Ltd (Fukuda Denshi) is a medical device company, which develops, manufactures, and commercializes medical equipment including cardiology, patient monitoring, vascular screening and ultrasound systems. The company’s product portfolio includes electrocardiographs, stress tests …
  • Western Gas Equity Partners LP:企業の戦略・SWOT・財務情報
    Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report Summary Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Xantrex LLC:企業の戦略的SWOT分析
    Xantrex LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ZESCO Ltd:企業の戦略的SWOT分析
    ZESCO Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • South Jersey Industries Inc (SJI):石油・ガス:M&Aディール及び事業提携情報
    Summary South Jersey Industries Inc (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also offer …
  • The AES Corp:企業の発電所・SWOT分析2018
    The AES Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execu …
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Baoding Lightway Green Energy Technology Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Baoding Lightway Green Energy Technology Co Ltd (Lightway), a subsidiary of LONGJITAIHE Group, is a vertically integrated solar module manufacturer. It specializes in the manufacture of high quality solar PV products, provides professional solutions and customer service. The company develops …
  • Petronas Dagangan Bhd (PETDAG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronas Dagangan Bhd (Petronas Dagangan), a subsidiary of Petroliam Nasional Berhad, is an oil and gas company that retails and markets downstream oil and gas products. The company operates through its business segments such as retail, commercial, liquefied petroleum gas and lubricants. It …
  • American States Water Company (AWR):企業の財務・戦略的SWOT分析
    Summary American States Water Company (AWR) is a utility service provider that offers water, wastewater and electric services. The utility provides operation, construction management and maintenance services for water and wastewater systems located on military bases across the US. It offers water se …
  • Breckenridge Pharmaceutical Inc:企業のM&A・事業提携・投資動向
    Breckenridge Pharmaceutical Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Breckenridge Pharmaceutical Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • SAS AB:戦略・SWOT・企業財務分析
    SAS AB - Strategy, SWOT and Corporate Finance Report Summary SAS AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • ABX Advanced Biochemical Compounds GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a provider of biochemical compounds that manufactures, develops, and distributes biochemicals for nuclear medicine. The company provides products such as PET and SPECT precursors and reference standards, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆